These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 305464)

  • 21. Synthetic phospholipid vesicles containing a purified viral antigen and cell membrane proteins stimulate the development of cytotoxic T lymphocytes.
    Loh D; Ross AH; Hale AH; Baltimore D; Eisen HN
    J Exp Med; 1979 Nov; 150(5):1067-74. PubMed ID: 227980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
    Sherman L; Mescher MF; Burakoff SJ
    J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary cytolytic T lymphocyte stimulation by purified H-2Kk in liposomes.
    Herrmann SH; Mescher MF
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2488-92. PubMed ID: 6972537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.
    Vidović D; Klein J; Nagy ZA
    J Immunol; 1984 Mar; 132(3):1113-7. PubMed ID: 6229577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helper T cells for cytotoxic T lymphocytes need not be I region restricted.
    Raulet DH; Bevan MJ
    J Exp Med; 1982 Jun; 155(6):1766-84. PubMed ID: 6176668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells.
    Balk SP; Mescher MF
    J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the induction of cytolytic T lymphocytes with alloantisera directed against H-2K and H-2D gene products.
    Lemonnier F; Burakoff SJ; Mescher M; Dorf ME; Benacerraf B
    J Immunol; 1978 May; 120(5):1717-20. PubMed ID: 307020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants.
    Melief CJ; de Waal LP; van der Meulen MY; Melvold RW; Kohn HI
    J Exp Med; 1980 May; 151(5):993-1013. PubMed ID: 6154770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G; Burakoff SJ; Abbas AK
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response.
    Von Hoegen P; Weber E; Schirrmacher V
    Eur J Immunol; 1988 Aug; 18(8):1159-66. PubMed ID: 2970967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary induction of cytotoxic T lymphocytes with solubilized syngeneic tumor cell plasma membranes.
    Alaba O; Law LW
    J Exp Med; 1978 Nov; 148(5):1435-9. PubMed ID: 309916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.
    Dennis JW; Donaghue TP; Carlow DA; Kerbel RS
    Cancer Res; 1981 Oct; 41(10):4010-9. PubMed ID: 6974593
    [No Abstract]   [Full Text] [Related]  

  • 40. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL.
    Schirrmacher V; Garrido F; Hübsch D; Garcia-Olivares E; Koszinowski U
    Transplant Proc; 1980 Mar; 12(1):32-7. PubMed ID: 6154357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.